The report on The Plasma Proteins Market in Canada – 2015/16 updates the same title published every two years. Two non-profit organizations (Canadian Blood Services and Héma-Québec) distribute most plasma and recombinant products, which distinguishes the market from other countries’. The effects of recent regulatory measures and on-going, economic and health care issues are examined in this report, which also provides sales data of all the major plasma-derived and recombinant proteins.

The report is delivered electronically (Excel and/or pdf files) and a hard copy is available. For more information or to order this report, please contact The Marketing Research Bureau at mrb_ibpn@earthlink.net, or +1 203 799-0298.

 


 

THE PLASMA PROTEINS MARKET IN CANADA
2015/2016

 

TABLE OF CONTENTS

Page

 

7

18

18

18

18

19

20

21

22

22

23

24

24

26

27

27

 

28

30

31

32

33

34

35

35

35

36

36

36

40

40

 

40

41

42

43

45

47

47

49

50

50

51

56

56

56

57

57

58

58

58

58

59

60

60

60

64

64

64

65

65

65

66

 

 

EXECUTIVE SUMMARY

HEALTH CARE ENVIRONMENT

BLOOD AND PLASMA COLLECTIONS

Historical Development

Blood Safety

Whole Blood Collections

Project Recovery

Remunerated Plasma Collection Controversy and Resolution

Canadian Blood Services (CBS)

Historical Development

Production and Distribution of Blood Components and Plasma Products

Héma-Québec (HQ)

Historical Development

Production and Distribution of Blood Components and Plasma Products

PLASMA FRACTIONATION

Historical Development

Contracts for Fractionation, Plasma-products and
Recombinant FVIII and FIX

Emergent BioSolutions (formerly Cangene Corporation)

Prometic Life Sciences

Therapure Biopharma

Green Cross Fractionation Plant

MARKET OVERVIEW

INTRAMUSCULAR IMMUNE GLOBULIN

Polyvalent Intramuscular Immune Globulin (IMIG)

Rho(D) Immune Globulin

Rabies Immune Globulin

Hepatitis A Immune Globulin

Hepatitis B Immune Globulin

Varicella Zoster Immune Globulin

Cytomegalovirus Hyperimmune Globulin

POLYVALENT INTRAVENOUS & SUBCUTANEOUS
IMMUNE GLOBULIN (IVIG & SCIG)

Intravenous Polyvalent Immune Globulin (IVIG)

Subcutaneous Polyvalent Immune Globulin (SCIG)

IgG Usage by Indication in Canada

Efforts to control IgG Usage

ALBUMIN MARKET

HEMOPHILIA CARE AND COAGULATION MARKET

Patient Population

Hemophilia Treatment

Factor VIII Market

Factor IX Market

Von Willebrand Disease Market

Inhibitors Market (APCC & rFVIIa)

Prevalence

Market Development

Prothrombin Complex Concentrate Market (PCC)

Other Bleeding Disorders

Factor VII

Factor XI

Factor XIII

Fibrinogen

OTHER PLASMA PRODUCTS

Alpha 1 Protease Inhibitor (A1PI)

C1 Esterase Inhibitor (C1-INH)

Antithrombin III

Protein C

Fibrin Sealant

Solvent Detergent-Treated Plasma (S/D Plasma)

PRICING AND DISTRIBUTION

MARKET TRENDS AND THREE-YEAR FORECAST

LIST OF MAJOR COMPANIES AND ORGANIZATIONS